Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports

Fig. 1

PRISMA flowchart of search strategy showing trials identified through literature search and previous meta-analyses, trial registers and through correspondence with YODA and regulators. RCTs, randomised controlled trials; EMA, European Medicines Agency; FDA, Food and Drug Administration; WHO, World Health Organisation; YODA, Yale Open Data Access. Asterisk indicates [27]; phi symbol, [28]; beta symbol, [65]; and Yen symbol [10]

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us